MedPage Today on MSN

FDA Approves Generic Flovent Inhaler for Asthma

Move comes 2 years after controversial exit of brand-name product ...

Asthma LABA medications do not increase severity of food allergy reactions during oral food challenges, study suggests

New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma ...
ConsumerAffairs

FDA approves new drug to treat adult asthma patients

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...
Healio

FDA accepts new drug application for single inhaler triple therapy in asthma

Please provide your email address to receive an email when new articles are posted on . The single inhaler includes an inhaled corticosteroid, a long-acting beta-agonist and an anticholinergic. The ...
EURweb

New Study Says We’ve Misunderstood the Real Cause of Asthma

*For decades, asthma treatment has focused on molecules called leukotrienes. These compounds cause inflammation, tighten airways, and make breathing harder. Drugs like Singulair were created to block ...